Lmb. Andersson et Mj. Warburton, INTRACELLULAR DEGRADATION OF TYPE-I COLLAGEN AND FIBRONECTIN IN HUMANLUNG FIBROBLASTS - EVIDENCE AGAINST DEGRADATION IN PRE-LYSOSOMAL COMPARTMENTS, Biochimica et biophysica acta. Molecular cell research, 1268(1), 1995, pp. 27-34
Fibroblasts degrade about 15% of newly synthesised collagen within the
cell before it can be secreted. When the helical structure of collage
n is disrupted, about 30% is degraded intracellularly. To determine if
collagen degradation occurs in a pre-lysosomal compartment, the passa
ge of type I collagen out of the endoplasmic reticulum or Golgi was in
hibited by incubating human lung fibroblasts with brefeldin A or monen
sin. In both cases, the type I collagen retained within the cell was s
table over a 20 h period. Disrupting the helical structure of collagen
with cis-hydroxyproline, 2,2'-bipyridyl or ethyl 3,4-dihydroxybenzoat
e did not alter the stability of type I collagen in brefeldin or monen
sin-treated cells. Incubating permeabilised cells in the presence of G
TP gamma S (guanosine 5'-(3-O-thio)triphosphate), which blocks transpo
rt out of the endoplasmic reticulum, also resulted in the stable reten
tion of type I collagen. Addition of dithiothreitol to permeabilised c
ells failed to initiate intracellular degradation. Similar results wer
e obtained with fibronectin. Both normal fibronectin and fibronectin i
n which canavanine replaced arginine were stable for 20 h in cells tre
ated with brefeldin A or monensin. The degradation of native collagen
is sensitive to inhibition by a cell-permeable cysteine proteinase inh
ibitor (ALLN) but is insensitive to chloroquine (which raises the pH o
f acidic intracellular compartments), whereas the degradation of abnor
mal collagen was sensitive to both ALLN and chloroquine. These results
argue against the intracellular degradation of collagen or fibronecti
n in a pre-lysosomal compartment.